Dieter Haag

Title: Dieter Haag: Innovator in Pharmaceutical Formulations

Introduction

Dieter Haag is a notable inventor based in Ramlinsburg, Switzerland. He has made significant contributions to the field of pharmaceutical formulations, particularly through his innovative work on crystalline compounds. His expertise and dedication to research have led to advancements that enhance the stability and efficacy of pharmaceutical products.

Latest Patents

Dieter Haag holds a patent for a unique compound titled "Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate." This invention focuses on a specific particle size distribution range and surface area range, which are crucial for improving the long-term stability and release kinetics of pharmaceutical compositions. The patent outlines the pharmacokinetic and pharmacodynamic profiles of the resultant free base after administration, showcasing the compound's potential in therapeutic applications.

Career Highlights

Dieter Haag is associated with Aicuris Anti-infective Cures AG, where he continues to push the boundaries of pharmaceutical innovation. His work has not only contributed to the development of new drugs but has also enhanced the understanding of how specific formulations can impact drug delivery and effectiveness.

Collaborations

Dieter collaborates with esteemed colleagues such as Wilfried Schwab and Alexander Birkmann. Their combined expertise fosters a dynamic research environment that drives innovation in the pharmaceutical industry.

Conclusion

Dieter Haag's contributions to pharmaceutical formulations exemplify the impact of innovative thinking in medicine. His patented work on crystalline compounds represents a significant advancement in drug stability and efficacy, highlighting the importance of research in improving healthcare outcomes.